Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological review of isobavachalcone, a naturally occurring chalcone
Miaojuan Wang, Ligen Lin, Jin-Jian Lu, et al.
Pharmacological Research (2021) Vol. 165, pp. 105483-105483
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Prenylated Flavonoids in Topical Infections and Wound Healing
Alice Sychrová, Gabriela Škovranová, Marie Čulenová, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4491-4491
Open Access | Times Cited: 40
Isobavachalcone exhibits antifungal and antibiofilm effects against C. albicans by disrupting cell wall/membrane integrity and inducing apoptosis and autophagy
Weidong Qian, Jiaxing Lu, Chang Gao, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 9
Isobavachalcone, a natural sirtuin 2 inhibitor, exhibits anti‐triple‐negative breast cancer efficacy in vitro and in vivo
Yali Ren, Jieting Lei, Tingrui Zhang, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 4, pp. 1815-1829
Closed Access | Times Cited: 7
A Systematic review on the phytochemistry, isolated compounds, nutritional benefits, pharmacology and toxicology of the plant species Morus alba L.
Pollobi Porasar, Rikngam Gibo, Bitu Gogoi, et al.
Discover Plants. (2025) Vol. 2, Iss. 1
Open Access
In vitro antibacterial and antibiofilm activities of isobavachalcone against Enterococcus faecalis clinical isolates from China
Lili Ouyang, Zhichao Xu, Yuanyuan Tang, et al.
BMC Microbiology (2025) Vol. 25, Iss. 1
Open Access
The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target
Gergely Róna, András Zeke, Bearach Miwatani-Minter, et al.
Cell Death and Differentiation (2021) Vol. 29, Iss. 2, pp. 285-292
Open Access | Times Cited: 46
Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives
Lele Zhang, Jifa Zhang, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 232, pp. 114176-114176
Closed Access | Times Cited: 31
Natural products from plants targeting key enzymes for the future development of antidiabetic agents
Rachel Mata, Laura Flores‐Bocanegra, Berenice Ovalle‐Magallanes, et al.
Natural Product Reports (2023) Vol. 40, Iss. 7, pp. 1198-1249
Closed Access | Times Cited: 19
Potential energy surface, effect of solvents in molecular level, experimental spectra (FTIR, Raman, UV–visible & NMR), electronic, and dynamics simulation of isobavachalcone –Anti tuberculosis agent
Nandini Mani, D. Nicksonsebastin, M. Prasath, et al.
Journal of Molecular Liquids (2023) Vol. 392, pp. 123465-123465
Closed Access | Times Cited: 19
Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive oxygen species induction
Qingwen Xiao, Bingling Zhong, Ying Hou, et al.
Free Radical Biology and Medicine (2023) Vol. 202, pp. 35-45
Closed Access | Times Cited: 16
Antimicrobial activities of natural flavonoids against foodborne pathogens and their application in food industry
Yanping Wu, Ling Jiang, Wenyi Ran, et al.
Food Chemistry (2024) Vol. 460, pp. 140476-140476
Closed Access | Times Cited: 5
Mechanisms of Azole Potentiation: Insights from Drug Repurposing Approaches
Juan Xiong, Hui Lu, Yuanying Jiang
ACS Infectious Diseases (2025)
Closed Access
Research Progress in the Molecular Mechanism of NLRP3 Inflammasome in Alzheimer’s Disease and Regulation by Natural Plant Products
Runru Zu, Lu Hao, Wanting Liu, et al.
Molecular Neurobiology (2025)
Closed Access
Natural sideromycins and siderophore-conjugated natural products as inspiration for novel antimicrobial agents
Zhiying Miao, Jing Lin, Wei‐Min Chen
European Journal of Medicinal Chemistry (2025), pp. 117333-117333
Closed Access
Natural products against tau hyperphosphorylation‐induced aggregates: Potential therapies for Alzheimer's disease
Gustavo Basurto‐Islas, Mario Dı́az, Lizeth M. Zavala Ocampo, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Open Access
Isobavachalcone-loaded electrospun polycaprolactone/gelatin nanofibers for antibacterial and antioxidant applications
Peibo Guo, Wen Zhang, Pei Zhao, et al.
Biomedical Materials (2025) Vol. 20, Iss. 2, pp. 025035-025035
Closed Access
Investigation of the mechanism of Isobavachalcone in treating rheumatoid arthritis through a combination strategy of network pharmacology and experimental verification
Shaohui Wang, Qinyun Du, Jiayi Sun, et al.
Journal of Ethnopharmacology (2022) Vol. 294, pp. 115342-115342
Closed Access | Times Cited: 26
Isobavachalcone: A comprehensive review of its plant sources, pharmacokinetics, toxicity, pharmacological activities and related molecular mechanisms
Nan Xing, Xianli Meng, Shaohui Wang
Phytotherapy Research (2022) Vol. 36, Iss. 8, pp. 3120-3142
Closed Access | Times Cited: 26
Antibacterial Activity of Isobavachalcone (IBC) Is Associated with Membrane Disruption
Letícia Ribeiro de Assis, Reinaldo dos Santos Theodoro, Maria Beatriz Silva Costa, et al.
Membranes (2022) Vol. 12, Iss. 3, pp. 269-269
Open Access | Times Cited: 25
The metal sensing applications of chalcones: The synthesis, characterization and theoretical calculations
Hüseyin Karaca, Sözcan Kazancı
Journal of Molecular Structure (2021) Vol. 1248, pp. 131454-131454
Closed Access | Times Cited: 28
3-Hydroxy-pyridin-4(1H)-ones as siderophores mediated delivery of isobavachalcone enhances antibacterial activity against pathogenic Pseudomonas aeruginosa
Yong-Jun Huang, Xiaolin Zhong, Yi-Peng Zang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115454-115454
Closed Access | Times Cited: 10
Isobavachalcone: A redox antifungal agent impairs the mitochondria protein of Cryptococcus neoformans
Xue Wang, Wen-Ting Zhou, Hui-Hua Dong, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 2, pp. 107253-107253
Open Access | Times Cited: 3
Isobavachalcone Exhibits Potent Antifungal Efficacy by Inhibiting Enolase Activity and Glycolysis in Candida albicans
Hao Wu, Zhe Ji, Xin Huang, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 8, pp. 3059-3070
Closed Access | Times Cited: 3
Inhibitory effects and mode of antifungal action of isobavachalcone on Candida albicans growth and virulence factors
Longfei Yang, Wenmao Li, Jianfeng Zhong, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117352-117352
Open Access | Times Cited: 3
Therapeutic potential of isobavachalcone, a natural flavonoid, in murine experimental colitis by inhibiting NF‐κB p65
Yishan Zhou, Bingling Zhong, Xiangjing Min, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 10, pp. 5861-5870
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top